4th World Forum on Infectious Diseases and Antimicrobial Resistance

Infectious Diseases and Global Health

Basic definition of infection refers to the harm caused by a foreign particle entering the host body. Some are mild and few are life-threatening depending on the type of organism causing it. Starting from the cause, symptoms, detecting the organism, clinical studies, treatment, controlling it before spreading, preventing the infection, developing new methods and techniques for diagnosis to developing new drugs and treatment strategies, you can discuss at our Euro Infectious Diseases 2020

The global market for infectious disease treatments is a result of the growth in demand for new pharmaceutical treatments, vaccines development, and environmental products. In 2017, the global market for the treatment of infectious disease totaled $64.8 billion. The market should total $99 billion by 2022, growing at a CAGR of 8.9% from 2017 to 2022.

Sub-Tracks

• Causes and pathophysiology
• Classification (Viral, Bacterial, Fungal and prion infections)
• Diagnosis and Prevention
• Prevalence and Epidemiology
• Clinical Studies
• Pharmaceutical Research
• Tropical Diseases 

Market Analysis:  The infectious diseases and global health market is a dynamic and expanding sector, primarily driven by the rising prevalence of infectious diseases, increasing antimicrobial resistance, and significant technological advancements. The market is broadly segmented into therapeutics (drugs and vaccines) and diagnostics. The therapeutics market, valued at around $124 billion to $243 billion, is dominated by viral infections and is projected to grow steadily, with North America holding the largest share due to its robust healthcare infrastructure and high R&D investment. Simultaneously, the infectious disease diagnostics market, valued at approximately $25 billion, is also seeing robust growth driven by the demand for rapid and accurate testing, particularly at the point of care.

The overall market is shaped by global health priorities, including pandemic preparedness, and is increasingly leveraging digital health technologies like telemedicine and AI to improve disease surveillance, diagnosis, and patient care, with the global digital health market alone projected to reach over $1.5 trillion by 2032. For more details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/infectious-diseases-and-global-health

Tags
Infectious Diseases Conferences Europe Paediatric Infectious Diseases Conferences Infectious Diseases Conferences Healthcare Conferences Epidemiology Conferences 2022 HIV/AIDS conferences Tropical Medicine Conferences Australia Influenza Conferences Clinical Microbiology Conferences Infection Conferences 2022 USA Pathology Conferences Infection Prevention & Control Conferences Asia Hepatitis Conferences Emerging Infectious Diseases Conferences Infectious Diseases Conferences

Viral Infections

These viral infections usually last for 7-10 days on which even medications won’t be much effective for the treatment. Resting and intake of fluids mostly work. But few cases like HIV, Ebola and Hepatitis are chronic and need to be treated with medications. Different viruses attack liver, respiratory system, or blood even. Immune system plays a critical role here and vaccination comes helpful in some cases.

Global virology market is estimated to witness significant growth over the forecast period. The global viral infections market will grow from $74 billion in 2014 to $117.6 billion by 2021, representing a CAGR of 6.8%

Sub-Tracks

• Coronavirus Infections
• Hepatitis
• Influenza and Respiratory Infections
• Encephalitis and Meningitis
• Gastrointestinal Infections
• Skin Infections
• Placenta and fetus infection
• Anti-viral drugs

Market Analysis: The global market for viral infection treatments is currently a high-value sector, estimated to be worth between $67 billion and $80 billion in 2025, with some broader infectious disease market analyses placing its value even higher. This market is forecasted to grow at a Compound Annual Growth Rate (CAGR) ranging from 5.3% to 7.0% through 2032, with projections that could push its value to nearly $135 billion by the end of that period. The market is led by therapeutics for major viral pathogens; for example, the HIV segment is projected to hold a substantial market share of 38%, while antivirals for influenza are also a significant component. North America continues to dominate the geographical market with a 39.7% share in 2025 due to its robust healthcare infrastructure and high treatment rates, while the Asia-Pacific region is the fastest-growing market, with a projected CAGR of 6.7%. This growth is underpinned by continuous advancements in drug development, a strong focus on combination therapies, and ongoing public health initiatives to combat viral outbreaks.

For More Details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/viral-infections

Tags
Parasitology Conferences Infection Conferences 2022 Emerging Infectious Diseases Conferences Infectious Diseases Conferences Immunologists Conferences 2022 Vaccines conferences Clinical Microbiology Conferences Infectious Diseases Conferences Virology Conferences Infectious Diseases Conferences Europe Paediatric Infectious Diseases Conferences HIV/AIDS conferences Healthcare Conferences Infection Prevention Conferences 2022 Pathology Conferences

Bacterial Infections

Unlike Viral infections, bacterial infections can be treated with medications, antibiotics. Many species are even beneficial to our body but few cause infections which can be effectively treated using antibiotics. Immunization prevent the onset of many bacterial infections. This session discusses the complete details of these infection and also the research being carried out to fight the bacteria which are becoming antibiotic resistant 

The global antibacterial drugs market was valued at $46.37Bn in 2018 and is estimated to increase at a CAGR of 1.5% from 2019 to 2027. North America stands first in the global antibacterial drugs market (2018). Global bacterial vaginosis drugs market research analysts estimate that it will generate revenue of almost USD 1 billion by 2021.

Sub-Tracks

• Tuberculosis
• Pneumonia
• Cholera and Diphtheria
• Bacterial Meningitis
• Tetanus
• Lyme disease
• Gonorrhea and Syphilis
• Skin and Urinary Tract Infections
• Sepsis & Septicemia

Market Analysis: The global request for bacterial infection treatments is poised for significant growth, with its value estimated at roughly$ 55.60 billion in 2025. This sector is projected to expand to$ 67.88 billion by 2030, flaunting a harmonious emulsion periodic growth rate( CAGR) of 4.07 from 2025. Geographically, while North America holds a dominant request share of 35.9, the Asia- Pacific region is the swift- growing request, driven by adding healthcare spending. The request is also defined by its remedial parts, with Cephalosporins holding a prominent share of 26.5 and broad- diapason antibiotics dominating the overall request at 54.2 in 2025. This expansion is unnaturally fueled by the rising global frequence of bacterial infections and the critical need for new curatives to combat medicine resistance, with major players and new medicine blessings continually shaping the competitive geography.

For More Details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/bacterial-infections

Tags
Infectious Diseases Conferences Europe Virology Conferences Infection Conferences 2022 Communicable Diseases Conferences 2022 Infectious Diseases Conferences Tropical Medicine Conferences Australia Infection Conferences 2022 USA Infection Prevention & Control Conferences Asia Epidemiology Conferences 2022 Parasitology Conferences Paediatric Infectious Diseases Conferences Influenza Conferences Infectious Diseases Conferences HIV/AIDS conferences Vaccines conferences

Fungal Infections

Fungal infection can be both superficial and can also penetrate deep inside the body. They trigger the immune system causing inflammation or tissue damage. Both the topical treatment and drugs are used to treat these infections. This session deals with all those aspects related to fungal infections 

The global antifungal drugs market size was valued at USD 11.3 billion in 2017. Raising prevalence of fungal infections such as Aspergillosis and Candidiasis is the key factor propelling the market. Global Antifungal Drugs Market is predicted to rise from 13,719 USD million in 2016 to 17,718 USD million by 2023. The industry is anticipated to register a CAGR of 3.7%, during the forecast period of 2017 - 2023. 

Sub-Tracks

• Aspergillosis and Candidiasis
• Athlete’s foot
• Ringworm and Yeast infections
• Skin Fungal Infections
• Fungal Diseases in Soil
• Anti-Fungal therapies

Market Analysis: The future of the fungal infections market is characterized by a shift towards more sophisticated, targeted, and innovative solutions, going beyond a simple increase in drug sales. While the anti-fungal drug market is forecasted to grow from roughly $17 billion in 2025 to over $22 billion by 2030, a key, unique driver of this expansion is the growing threat of antifungal resistance, which is prompting a new wave of research and development. This has led to the emergence of novel drug classes, such as triterpenoids like ibrexafungerp, which offer new mechanisms of action to combat pathogens that have become resistant to existing treatments. Simultaneously, the market for fungal diagnostics is experiencing an even faster growth trajectory, with a projected CAGR of 9.5% to reach an estimated $4.9 billion by 2032. This is driven by a critical need for rapid and accurate identification of specific fungal species and their resistance profiles, enabling personalized and more effective treatment. A further and increasingly unique factor shaping the market is climate change, which is expanding the geographic range of pathogenic fungi like Coccidioides and increasing their virulence. This environmental factor, coupled with a growing population of immunocompromised individuals, is creating a "perfect storm" that is forcing a re-evaluation of public health strategies and driving demand for new and accessible therapies to address this evolving global threat. 

for more details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/fungal-infections

Tags
Pathology Conferences Infectious Diseases Conferences 2022 Influenza Conferences Infectious Diseases Conferences 2022 Infectious Diseases Conferences Middle East Infection Conferences 2022 Tropical Medicine Conferences Australia Infectious Diseases Conferences Infectious Diseases Conferences Immunologists Conferences 2022 Infection Conferences Paediatric Infectious Diseases Conferences Antimicrobial Conferences Infectious Diseases Conferences Europe Infection Prevention & Control Conferences Asia

Vector-borne Diseases

These are the infections transmitted by the mosquitoes, bugs, ticks, flies etc. One major factor that influences their growth is climate. These accounts for more than 17 percent of all infectious diseases. Dengue and Malaria are the major ones causing more number of deaths. Maintaining clean and proper environmental factors and social factors will helps in disease control and elimination

Global Anti-Malarial Drugs market reached USD 742.5 Million in 2016 at a CAGR of 3.2% across the world. The market is predicted as USD 1,049.5 Million by 2027. Middle East & Africa accounts for a share of 51.0% by 2027 and Asia Pacific of 30.2% by 2027. Moreover, the market is anticipated to account $317.0 Million by 2027 from $222.8 Million in 2016. China & India is the major contributor to the growth of Asia Pacific Anti-Malarial Drugs market. 

Sub-Tracks

• Malaria
• Dengue fever and Chikungunya
• Leishmaniasis and Yellow fever
• Zika and Lymphatic filariasis
• Schistosomiasis
• Japanese encephalitis and Onchocerciasis

Market Analysis: The global market for vector-borne diseases is poised for substantial growth, driven by a confluence of public health challenges and technological advancements. The vector control market, a major component, was valued at approximately $22.22 billion in 2025 and is projected to reach $30.14 billion by 2030, with a CAGR of 6.24%. This expansion is fueled by the rising incidence of diseases like dengue and malaria, which are spreading to new geographic regions due to climate change and rapid urbanization. While North America currently holds the largest market share, the Asia-Pacific region is anticipated to be the fastest-growing market, with a forecasted CAGR of 7.28% between 2024 and 2031, due to its high population density and significant disease burden. The market's evolution is also being shaped by a shift toward more sustainable and technologically advanced solutions. This includes a growing demand for biological control methods, AI-driven surveillance systems, and a move away from traditional chemical-based insecticides as vectors develop resistance.

For More Details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/vector-borne-diseases

Tags
HIV/AIDS conferences Infectious Diseases Conferences 2022 Emerging Infectious Diseases Conferences Epidemiology Conferences Infectious Diseases Conferences Infection Conferences Infection Control Conferences Paediatric Infectious Diseases Conferences Antimicrobial Conferences Infection Conferences 2022 Asia Vaccines conferences Infectious Diseases Conferences 2022 Clinical Microbiology Conferences Infectious Diseases Conferences Influenza Conferences

Virology and HIVAIDS

With the continuous emerging of new strains of viruses, virologists played a major role in finding new advancements to fight against them. They became the most complex organisms causing dreadful diseases. One among them is the HIV-1, a retrovirus causing AIDS making the immune system the primary target. It has been around 20 years, our scientists researching on this HIV and though antiretroviral drugs reduced the mortality rate, still lot more research to be done to eradicate this completely. Join us and share your thoughts alos on this hot topic

In 2019, the global antiviral drugs market size was valued at $56.4 billion and is expected to register a CAGR of 2.3% over the estimated period. Around 1,848 pipeline products are specifically in development for treating the viral infections. Global HIV Drug Market was valued at USD20,448 million in 2015 and is predicted to reach USD26,458 million by 2022, at a CAGR of 3.7% during the forecast period of 2016-2022. 

Sub-Tracks

• Molecular virology of HIV & Viral Therapy
• Viral genomes
• Viral Pathogenesis and Immunity
• Viral Evolution and Emerging Viruses
• HIV/AIDS Epidemiological Statistics
• Anti-HIV Drugs 
• Animal Models of HIV Infection and Disease

Market Analysis: projecting a steady and robust expansion. Instead of the previously cited figures, a more current analysis indicates the market, valued at $2.96 billion in 2024, is expected to reach $5.31 billion by 2030, reflecting a substantial CAGR of 10.3%. This upward trajectory is primarily fueled by a paradigm shift towards more accessible testing methods, such as point-of-care (POC) and at-home self-testing kits, which are gaining traction due to their convenience, privacy, and speed. Furthermore, the market is being propelled by increased government initiatives and global health campaigns, including those by UNAIDS, which are intensifying efforts to meet ambitious testing and treatment targets. Technological innovations, such as the integration of molecular diagnostics and multiplex platforms that can test for multiple infections simultaneously, are also key drivers, enhancing the accuracy and efficiency of diagnostic tools. This combination of rising awareness, supportive policies, and advanced technology is set to redefine the landscape of HIV diagnostics and significantly boost its market value in the coming years.

For More Details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/virology-and-hivaids

Tags
Vaccines conferences Infection Conferences 2022 Asia Healthcare Conferences Virology Conferences Infectious Diseases Conferences Infectious Diseases Conferences Middle East Communicable Diseases Conferences 2022 Infectious Diseases Conferences Europe Immunologists Conferences 2022 Infectious Diseases Conferences Emerging Infectious Diseases Conferences Antimicrobial Conferences Hepatitis Conferences Epidemiology Conferences 2022 Infection Conferences 2022

Immunology and Clinical Microbiology

To understand the infectious diseases, we need to study deeply both the immunology and microbiology as one focuses on host and the other on pathogen affecting the host. Here we planned this particular session to discuss in detail to have better understanding of Infectious diseases including genetics, biochemistry, molecular and computational biology, molecular and cellular components of the immune system 

Global immunology treatment market is set to expand, from $61.5 billion in 2015 to reach $74.2 billion in 2022. The pharmaceutical pipeline for immunology is countable, currently with 1,896 products in active development. 85 of these are in Phase III and 73% of these pipeline products are in the early developmental stages. The global immunology market size was USD 77,365.4 Million in 2018 and is estimated to reach USD 143,833.2 Million by 2026  

Sub-Tracks

• Immunology and Hypersensitivity
• Host-Microbe Interactions and Pathogenesis
• Molecular and Cellular Mechanisms
• Molecular Genetics
• Autoimmune and Inflammatory Diseases

Market Analysis: The global immunology and clinical microbiology markets are both experiencing robust growth, driven by a confluence of technological advancements and the increasing global burden of infectious and autoimmune diseases. The immunology market is currently valued at approximately $116.4 billion in 2025 and is projected to reach $206.58 billion by 2034, with a notable compound annual growth rate (CAGR) of about 6.58%. This significant expansion is primarily fueled by the development and adoption of innovative therapies, particularly monoclonal antibodies (mAbs), which are the dominant product segment. The clinical microbiology market, on the other hand, is valued at an estimated $5.26 billion in 2025 and is projected to grow to $7.71 billion by 2032, with a CAGR of around 5.6%. The growth in this sector is largely propelled by the increasing prevalence of infectious diseases and the urgent need for rapid, accurate diagnostics to combat issues like antimicrobial resistance. The growth in both markets is driven by several key factors. The rising incidence of autoimmune conditions like rheumatoid arthritis and infectious diseases, including those caused by drug-resistant pathogens, creates a continuous demand for advanced diagnostic tools and effective treatments. Technological innovations are transforming both fields, with a shift towards rapid, automated, and high-throughput methods. For instance, in clinical microbiology, traditional culture-based techniques are being replaced by advanced molecular diagnostics such as PCR, Next-Generation Sequencing (NGS), and MALDI-TOF mass spectrometry. Similarly, in immunology, the focus on personalized medicine is leading to the development of tailored immunotherapies. However, both markets face challenges, including the high cost of advanced instruments and therapies, stringent regulatory processes, and a persistent shortage of skilled professionals, which can limit their full growth potential. Overall, these markets are poised for sustained growth, driven by an evolving landscape of scientific innovation and pressing global health needs. 

For More Details : https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/immunology-and-clinical-microbiology

Tags
Antimicrobial Conferences Parasitology Conferences Tropical Medicine Conferences Australia Infectious Diseases Conferences Europe Infection Control Conferences Vaccines conferences Emerging Infectious Diseases Conferences Virology Conferences Paediatric Infectious Diseases Conferences Infectious Diseases Conferences Infectious Diseases Conferences Infection Conferences Healthcare Conferences Immunologists Conferences 2022 Infectious Diseases Conferences 2022

Neurological and CNS Infections

Bacteria, Virus and Fungi can even affect the Central Nervous System of our body. They may affect brain, spinal cord, neurons at any level. Initial prognosis and diagnosis is essentially required to save the life. Share your research work and help many individuals facing adverse consequences because of these infections

The global Central Nervous System therapeutic market size was worth $77.2 billion in 2016 and is expected to grow at a CAGR of 5.9% during the forecast period. The annual incidence of bacterial CNS infections has been 36.3/100,000 and that of viral infections is 688.0/100 000. 

Sub-Tracks

• Encephalitis
• Prion diseases
• Meningitis
• Brain abscesses

Market Analysis: The market for neurological and central nervous system (CNS) therapeutics, a broader category that includes treatments for a wide range of conditions, is currently valued at approximately $134.42 billion in 2025. It is projected to experience substantial growth, reaching an estimated $185.90 billion by 2030, with a notable compound annual growth rate (CAGR) of 6.70%. This expansion is propelled by several key drivers. Firstly, a globally aging population is leading to a higher prevalence of neurodegenerative diseases, such as Alzheimer's and Parkinson's, which are the fastest-growing segment and are expected to drive significant demand for novel therapies. Secondly, advancements in diagnostics, including neuroimaging and biomarker-based testing, are enabling earlier and more accurate diagnosis, thereby expanding the patient population eligible for treatment. Additionally, a renewed focus on R&D by pharmaceutical companies is leading to the development of cutting-edge treatments like gene therapy, personalized medicine, and AI-driven drug discovery, which are revolutionizing the landscape. North America currently holds the largest market share, fueled by its robust healthcare infrastructure and high R&D investments, while the Asia-Pacific region is poised to be the fastest-growing market due to its large population and improving healthcare expenditure. However, the market faces certain restraints, including high clinical trial failure rates, the substantial cost of advanced therapies, and the persistent challenge of the blood-brain barrier for drug delivery, which can hinder market growth despite the immense clinical need.

For More Details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/neurological-and-cns-infections

Tags
Infection Conferences 2022 USA Hepatitis Conferences Infection Prevention & Control Conferences Asia Infectious Diseases Conferences Europe Clinical Microbiology Conferences Antimicrobial Conferences Infection Conferences Epidemiology Conferences Infectious Diseases Conferences 2022 Infectious Diseases Conferences Parasitology Conferences Epidemiology Conferences 2022 Infectious Diseases Conferences Tropical Medicine Conferences Australia Infection Prevention Conferences 2022

Healthcare-Associated Infections

HAIs are the infections that people usually get when they are getting treated for some other disease/disorder. These are having devastating consequences and may be the significant cause of illness and death. Hospitals, surgical centers, clinics are the major places for these kind of infections. 1 among every 25 hospitalized patients acquire HAIs so there comes the need of discussions on these Healthcare associated Infections

Sub-Tracks

• Central line-associated bloodstream infection (CLABSI)
• Methicillin-resistant Staphylococcus aureus (MRSA) 
• Catheter-associated urinary tract infections
• Surgical site infections
• Bloodstream infections
• Clostridium difficile infections

Market Analysis: The Healthcare-Associated Infections (HAIs) diagnostics market is poised for significant future expansion, driven by the critical need for swift and accurate pathogen detection to combat rising antimicrobial resistance. The market, which was valued at an estimated $4.3 billion in 2024, is projected to reach $4.74 billion by 2030, reflecting a CAGR of 1.5% over the forecast period. This growth is being propelled by the rapid adoption of advanced technologies, particularly molecular diagnostics, which are set to grow at the fastest rate of 1.71% CAGR due to their superior speed and precision in identifying infectious agents. The market is also benefiting from a growing emphasis on point-of-care (POC) and rapid diagnostic testing, as these solutions enable healthcare providers to make timely clinical decisions, improve patient outcomes, and streamline infection control protocols. While North America remains a dominant force with its advanced healthcare infrastructure, the Asia-Pacific region is emerging as the fastest-growing market, with an anticipated CAGR of 2.29% for diagnostics, driven by increasing healthcare investments and a growing awareness of infection prevention. This dynamic landscape highlights a shift towards more proactive and technologically-driven approaches to manage and contain the spread of HAIs.

For More Details: https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/healthcare-associated-infections

Tags
Emerging Infectious Diseases Conferences Paediatric Infectious Diseases Conferences Infection Prevention Conferences 2022 Infection Conferences 2022 Asia Infectious Diseases Conferences Europe Infectious Diseases Conferences Pathology Conferences Infectious Diseases Conferences Tropical Medicine Conferences Australia Infection Conferences Immunologists Conferences 2022 Infection Prevention & Control Conferences Asia Infectious Diseases Conferences Parasitology Conferences Hepatitis Conferences

Ophthalmological Infectious Diseases

As mentioned earlier above, emerging infectious diseases became life threatening because of globalization. Now these find their way even in Ophthalmology causing infections to eye. This session describes the infections of eye in detail and how they can be diagnosed and treated with the recent advancements of the research field

Sub-Tracks

• Retinitis and Chorioretinitis
• Retinal Vasculitis
• Optic Neuropathy
• Ocular Immunology
• Trachoma and Conjuctivitis

Market Analysis: The global ophthalmological infectious-disease therapeutics market (eye-infection treatment) is currently estimated at about USD 8.16 billion in 2025 and is projected to reach USD 9.83 billion by 2030 (CAGR ~3.8%), driven by steady volumes of bacterial, viral, and fungal eye infections, expanding OTC access to anti-infective drops, and incremental innovation in sustained-release delivery and combination formulas. Within this, conjunctivitis remains the largest revenue pool, at ~USD 4.53 billion in 2025 and tracking toward ~USD 5.54 billion by 2030 (CAGR ~4.1%); the viral conjunctivitis drugs niche is expected to rise from ~USD 375 million in 2025 to ~USD 531 million by 2032 (CAGR ~5.1%), reflecting periodic outbreaks and heightened hygiene awareness. By geography, mature markets continue to anchor absolute dollars while emerging Asia adds the fastest unit growth; for example, the U.S. alone is expected to take conjunctivitis treatment revenues to ~USD 1.6 billion by 2030 (CAGR ~3.8%) on stable prescribing and aging demographics. Looking at product classes, ophthalmic anti-infectives as a category are on track to reach roughly USD 6.5 billion by 2033, indicating durable demand for topical antibiotics/antivirals even amid generic erosion, while enabling technologies such as ophthalmic drug-delivery systems are forecast to expand to ~USD 23.36 billion by 2030 (CAGR ~6.6% from mid-decade), supporting longer-acting inserts and improved adherence that lift branded value capture. Altogether, these trajectories imply a mid-single-digit growth profile for infectious ophthalmology through 2030+, with upside tied to launches that shorten dosing cycles or address resistance patterns, and downside chiefly from patent cliffs and continued genericization of first-line antibiotics.

For More Details : https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/ophthalmological-infectious-diseases

Tags
Infection Conferences 2022 Asia Infectious Diseases Conferences 2022 Epidemiology Conferences 2022 Influenza Conferences Pathology Conferences Infectious Diseases Conferences Infection Prevention & Control Conferences Asia Clinical Microbiology Conferences Infection Control Conferences Infection Prevention Conferences 2022 Tropical Medicine Conferences Australia Paediatric Infectious Diseases Conferences Immunologists Conferences 2022 Antimicrobial Conferences Infectious Diseases Conferences

Lower Respiratory and Pediatric IDs

Neonatal Diseases are very common as they will be consistently subjected to the infections caused by microbes. They can be of any reason/unknown reason or acquired from mother. Special attention should be given while treating them with the medications/vaccines or course of medications as their body molecular structure will be different and sensitive from that of adults especially while treating life threatening diseases. Learn more from the physicians and specialists expertise in the pediatric care

Sub-Tracks

• Immune deficiency diseases
• Encephalitis
• Lymphadenopathy
• HIV and Lyme disease
• Osteomyelitis
• Pneumonia and Tuberculosis
   

Tags
HIV/AIDS conferences Pathology Conferences Emerging Infectious Diseases Conferences Epidemiology Conferences 2022 Infectious Diseases Conferences Antimicrobial Conferences Tropical Medicine Conferences Australia Immunologists Conferences 2022 Infection Prevention & Control Conferences Asia Infectious Diseases Conferences Europe Infectious Diseases Conferences Healthcare Conferences Infection Conferences 2022 USA Paediatric Infectious Diseases Conferences Influenza Conferences

Genomics and Infectious disease

This became the most interesting field now a days with the evolving nature of microbes. To know the information of an infection and its epidemiology etc the genomic study of the microbial strains is the only way to study about the disease further. Thus it plays a major role in prognosis, drug development, diagnosis and its epidemic control etc

• Genome sequencing
• Genomic advances
• Research Studies and reports
• Clinical and Epidemiologic studies
• Current Clinical Applications

Tags
Clinical Microbiology Conferences Infectious Diseases Conferences Europe Infection Control Conferences Communicable Diseases Conferences 2022 Infectious Diseases Conferences 2022 Hepatitis Conferences Epidemiology Conferences Healthcare Conferences Emerging Infectious Diseases Conferences Immunologists Conferences 2022 Vaccines conferences Infectious Diseases Conferences Middle East Infectious Diseases Conferences 2022 Paediatric Infectious Diseases Conferences Infection Conferences 2022

Special Session on COVID-19

Coronaviruses cause illness to humans ranging from the common cold to dreadful diseases. COVID-19 is a new strain discovered in the year 2019 which has not identified previously in humans. They are transmitted from animals to humans. Common signs include respiratory discomfort, fever and cough, shortness of breath and breathing difficulties. To prevent the spreading of the infection regular hand washing, covering mouth and nose while coughing and sneezing, thoroughly cooking meat and eggs is highly recommended. It is better to avoid close contact with the one showing symptoms of respiratory illness such as coughing and sneezing.

This session was designed to discuss the recent research going on which will aid in giving new ideas and new ways to combat this dreadful disease spreading all across the globe.

Tags
HIV/AIDS conferences Antimicrobial Conferences Pathology Conferences Infectious Diseases Conferences 2022 Paediatric Infectious Diseases Conferences Infectious Diseases Conferences Hepatitis Conferences Communicable Diseases Conferences 2022 Infection Prevention Conferences 2022 Epidemiology Conferences Virology Conferences Infection Conferences 2022 USA Infectious Diseases Conferences 2022 Infection Conferences 2022 Infectious Diseases Conferences Europe

Vaccines and Immunizations

Unlike other drugs used to treat the diseases, vaccines completely prevent the disease and thus became the effective way of treatment for many dangerous life threatening diseases. Immunization or Vaccination is generally done in childhood age to protect against the infection. Various forms of vaccinations were discovered. There by discussions will be on different types of vaccines for infections, their research and development stages etc..

Global vaccines market is estimated to reach $58.4 billion by 2024 from $41.7 billion in 2019, at a CAGR of 7.0% during the forecast period. This is driven by the rise in prevalence of infectious diseases and vaccines are considered the best way to prevent these infectious diseases. 

Sub-Tracks

• Vaccine Research & Development
• Vaccines safety & Efficacy
• Live-attenuated and Inactivated vaccines
• Conjugate and Toxoid vaccines
• Immunization for Women

Market Analysis: The vaccines and immunizations market is entering 2025 on a strong growth trajectory, with revenues estimated at nearly USD 84 billion and projected to reach close to USD 115 billion by 2030, representing a sustained CAGR of about 6–7%. This expansion is being fueled by steady global demand for influenza, HPV, and pediatric vaccines, alongside heightened adoption of adult immunization programs and booster campaigns for respiratory illnesses. A particularly dynamic segment is mRNA-based vaccines, which account for more than USD 10 billion in 2025 and are forecast to nearly double to USD 18 billion by 2030 at an impressive ~12% CAGR, underlining the growing role of novel platforms in shaping the future of preventive care. Forward-looking analyses suggest that if next-generation delivery systems and therapeutic vaccines achieve wider clinical adoption, the overall market could surpass USD 150 billion by the mid-2030s. Numerically, this positions vaccines and immunizations as one of the most resilient sectors in healthcare, balancing predictable baseline demand with high-growth opportunities in innovation-driven subsegments.

For More Details : https://microbiology-infectiousdiseases.peersalleyconferences.com/tracks/vaccines-and-immunizations

Tags
Infectious Diseases Conferences Infection Prevention & Control Conferences Asia Epidemiology Conferences Infectious Diseases Conferences 2022 Infectious Diseases Conferences Europe Antimicrobial Conferences Virology Conferences Infectious Diseases Conferences Middle East Infectious Diseases Conferences Infection Prevention Conferences 2022 Pathology Conferences Infection Conferences 2022 Asia Vaccines conferences Infection Control Conferences HIV/AIDS conferences

Tropical Diseases and Parasitic Diseases

Some bacterial and viral infections are restricted to specific tropical/sub-tropical regions causing Tropical diseases. This may be due to environmental/biological factors. Neglected tropical diseases (NTDs) are also the cases reported in these regions of low and middle income countries who don’t have proper sanitation in their living areas. Effective control need to be achieved by educating everyone with proper health approaches. 

Parasites are the small organisms causing various types of infections in the host body. Even though all these are interlinked there is need to specifically address these parasitic diseases as many contagious diseases were reported from these. 

The global neglected tropical disease treatment market size was accounted for $1.2 billion in 2018 and is estimated to grow at a CAGR of 5.5% over the forecast period. The global parasitic diseases therapeutics market size might grow by $1.79 billion during 2019 to 2023. 
 

Sub-Tracks

• Neurocysticercosis
• Giardia and Helminthiasis
• Leishmaniasis
• Schistosomiasis and Trichinosis
• Human African Trypanosomiasis 
   

Tags
Epidemiology Conferences 2022 Paediatric Infectious Diseases Conferences Tropical Medicine Conferences Australia Immunologists Conferences 2022 Communicable Diseases Conferences 2022 Virology Conferences Infectious Diseases Conferences 2022 HIV/AIDS conferences Antimicrobial Conferences Infectious Diseases Conferences 2022 Infectious Diseases Conferences Epidemiology Conferences Infection Prevention Conferences 2022 Emerging Infectious Diseases Conferences Infection Conferences 2022 Asia

Sexually Transmitted Diseases and STIs

STDs and STIs are having a profound impact on sexual and reproductive health globally. Every year, there are an estimated 376 million new infections. Gonorrhoea, Chlamydia, Syphilis and Trichomoniasis are most commonly seen. HSV and HPV are the viruses causing these infections. These are causing the major death in women and newborns which need to be focused on. 

In 2017, global STD testing market was valued for $ 86,548.0 million. It is predicted to reach USD 133,935.7 million by 2025, at a CAGR of 5.6% from 2018- 2025. The diagnosis of these STDs caused by Syphilis is rising and is expected to account for over 20% of the market by 2022, growing at a CAGR over the forecast period due to high prevalence of syphilis infections globally. 

Sub-Tracks

• Chlamydia
• Genital herpes
• Trichomoniasis
• Syphilis and Gonorrhea
• Other STDs
   

Tags
Pathology Conferences Infectious Diseases Conferences 2022 Infection Conferences Infection Conferences 2022 Asia Epidemiology Conferences 2022 Virology Conferences Infectious Diseases Conferences Antimicrobial Conferences Infection Control Conferences HIV/AIDS conferences Infectious Diseases Conferences Clinical Microbiology Conferences Hepatitis Conferences Epidemiology Conferences Emerging Infectious Diseases Conferences

Pathophysiology and Diagnosis

Knowing about these Infectious Diseases is much more important to proceed for the treatment. Here comes the necessity of studying pathophysiology of the diseases and also the correct and accurate method for diagnosing it. Many advancements took place in the field of diagnostic studies. Let’s discuss about all the research advancements and pathophysiological studies

Sub-Tracks

• Pathogenesis
• Modes of Transmission
• Antimicrobials/Antimicrobial Resistance
• Molecular Methods
• Infectious Agents and defense mechanisms 
• Novel methods and techniques
   

Tags
Infection Prevention Conferences 2022 Tropical Medicine Conferences Australia Emerging Infectious Diseases Conferences Vaccines conferences Healthcare Conferences Infection Conferences 2022 Asia Clinical Microbiology Conferences Infectious Diseases Conferences Middle East Epidemiology Conferences Infection Conferences 2022 USA Communicable Diseases Conferences 2022 Immunologists Conferences 2022 HIV/AIDS conferences Infection Control Conferences Epidemiology Conferences 2022

Clinical Trials and Case Studies

Clinical Trails are very important before releasing a novel medicine to the market. It might take few years to complete. Not only for treatment methods but also for diagnosing or detecting new possible ways to treat diseases. Case studies play equal importance in exploratory research. These provide the clinical evidence documentation which can be helpful for the fellow researchers to study as well

Sub-Tracks

• Evaluation of Safety and Efficacy of novel drugs
• Research studies on IDs
• Reviews on IDs
• Drug Developmental Stages
• Animal and Mathematical Models
   

Tags
Infectious Diseases Conferences Infection Conferences 2022 Tropical Medicine Conferences Australia Infection Prevention & Control Conferences Asia Pathology Conferences Infection Control Conferences Infectious Diseases Conferences Epidemiology Conferences 2022 Infectious Diseases Conferences Middle East Virology Conferences Influenza Conferences HIV/AIDS conferences Clinical Microbiology Conferences Infection Conferences Infection Conferences 2022 USA

Influencing Factors of IDs

Now comes the session explaining the factors that influences the onset and spreading of Infectious Diseases. These may vary from environmental to biological. A brief idea about the factors helps for the further study regarding the diseases. 

Sub-Tracks

• Environmental factors
• Biological and Social factors
• Human and physical resources
• Food and Water borne infections
• Veterinary infectious Diseases
   

Tags
Vaccines conferences Healthcare Conferences Pathology Conferences HIV/AIDS conferences Infection Conferences 2022 Asia Clinical Microbiology Conferences Infectious Diseases Conferences Europe Parasitology Conferences Influenza Conferences Infection Prevention & Control Conferences Asia Epidemiology Conferences 2022 Antimicrobial Conferences Infectious Diseases Conferences 2022 Infection Conferences 2022 USA Paediatric Infectious Diseases Conferences

Advanced Treatments and Technologies

With the overview we had about the IDs, our scientists have designed many medications and vaccines to prevent the diseases which had effectively showed the results. But due to emerging forms of infections still we have been struggling to fight against the infections. This session helps to discuss regarding the strategies or methods which are being developed. 

Sub-Tracks

• Novel Drug Therapies 
• Novel imaging and screening techniques
• Technologies and devices
• Biomarkers
• Antibiotics, antiviral drugs and vaccines
• Infection and Drug Resistance
• Nursing Care Practices
   

Tags
Virology Conferences Tropical Medicine Conferences Australia Epidemiology Conferences Emerging Infectious Diseases Conferences Infection Prevention Conferences 2022 Infection Conferences Communicable Diseases Conferences 2022 Healthcare Conferences Antimicrobial Conferences Infectious Diseases Conferences Infection Prevention & Control Conferences Asia Infectious Diseases Conferences Europe Infection Control Conferences Vaccines conferences Infection Conferences 2022 Asia

Prevention and Control

IDs still became a major concern occurring frequently across the world. There is definite necessity to follow few things to prevent or control these diseases. This session includes those preventive measures to be taken and follow for well-being of every individual. This includes maintaining hygienic environment within and around ourselves taking individual responsibility and following the guidelines issued by the authorities in regards to health and safety

Sub-Tracks

• Vaccination
• Genomic study
• Antibiotics and Anti-microbials
• Biochemical Tests
• Drugs and risk factors
   

Tags
Healthcare Conferences Paediatric Infectious Diseases Conferences Hepatitis Conferences Emerging Infectious Diseases Conferences Virology Conferences Pathology Conferences HIV/AIDS conferences Immunologists Conferences 2022 Infectious Diseases Conferences Europe Infectious Diseases Conferences Communicable Diseases Conferences 2022 Antimicrobial Conferences Vaccines conferences Infectious Diseases Conferences 2022 Infection Conferences 2022

Public Health and Epidemiology

Epidemiology of an infectious disease (ID) involves the study of prevalence and incidence of infections to better understand the burden and causes among the populations. These are one of the major cause of morbidity and mortality globally. The study ranges from the search of novel pathogens, Causative organism, Host, Mode of transmission, Incubation period, usual symptoms, complications and mortality rate using advanced molecular techniques to population based studies to explain the transmission dynamics & spectrum of disease.

Sub-Tracks

• Endemic, Epidemic and Pandemic cases
• Disease agent, host and the environment
• Global Burden 
• Infectious Disease Spectrum studies
• Public Health Surveillance studies
• Data collection, Analysis, Interpretation and Dissemination
   

Tags
Infectious Diseases Conferences Middle East Paediatric Infectious Diseases Conferences Influenza Conferences Infectious Diseases Conferences Europe Infection Control Conferences Epidemiology Conferences 2022 Communicable Diseases Conferences 2022 Epidemiology Conferences Parasitology Conferences Antimicrobial Conferences Infection Prevention & Control Conferences Asia Infectious Diseases Conferences 2022 Tropical Medicine Conferences Australia Infectious Diseases Conferences 2022 Emerging Infectious Diseases Conferences

Oral and Maxillofacial Infections

Odontogenic infections are mostly and frequently seen among the individuals. Due to the advancements in the medical field, techniques, antibiotic usage and genetics there is a need to discuss the advancements in this specific field 

• Epidemiological characteristics
• Microbiological analysis 
• Treatment Techniques 
• Controversies 

Tags
Infectious Diseases Conferences Middle East Tropical Medicine Conferences Australia Paediatric Infectious Diseases Conferences Clinical Microbiology Conferences Infection Control Conferences Infectious Diseases Conferences 2022 Epidemiology Conferences Influenza Conferences Infectious Diseases Conferences Epidemiology Conferences 2022 Infectious Diseases Conferences Europe Infectious Diseases Conferences Immunologists Conferences 2022 Antimicrobial Conferences Infection Conferences 2022